Filtern
Volltext vorhanden
- ja (15)
Gehört zur Bibliographie
- ja (15)
Dokumenttyp
Sprache
- Englisch (15)
Schlagworte
- blood-brain barrier (4)
- blood brain barrier (3)
- blood–brain barrier (3)
- endothelial cells (3)
- CNS disorders (2)
- brain (2)
- cEND (2)
- claudin-1 (2)
- glucocorticoid receptor (2)
- neuropathic pain (2)
- tight junctions (2)
- 3D ex vivo models (1)
- 3D in vitro model (1)
- CNS diseases (1)
- CNS injury (1)
- CRPS (1)
- Expression (1)
- IL-6 (1)
- MMP9 (1)
- MPS1 (1)
- Pain (1)
- RECK (1)
- TTFields (1)
- Transwell® system (1)
- Tumor Treating Fields (TTFields) (1)
- Tumor-Treating Fields (TTFields) (1)
- ZO-1 (1)
- aggregation (1)
- aging (1)
- astrocytes (1)
- astrocytoma (1)
- barrier properties (1)
- blood nerve barrier (1)
- blood-nerve barrier (1)
- brain pathology (1)
- calcium level (1)
- cell stretch (1)
- cerebEND (1)
- cerebEND cells (1)
- cerebral ischemia (1)
- chronic constriction injury (1)
- cyclodextrin formulations (1)
- cytokine expression (1)
- cytotoxicity (1)
- dexamethasone (1)
- drug transporter (1)
- ether (1)
- etomidate (1)
- expression (1)
- fluorescein isothiocyanate (1)
- fluorescence microscopy (1)
- formulations (1)
- glioblastoma (1)
- glioblastoma multiforme (1)
- glucocorticoids (1)
- human brain microvascular endothelial cells (HBMVEC) (1)
- human cells (1)
- hydrochloride (1)
- hypoxia (1)
- immortalization (1)
- immunology (1)
- in vitro (1)
- in vitro cell culture models (1)
- in vitro model (1)
- intestinal absorption (1)
- ischemia (1)
- isosteviol sodium (1)
- isosteviol sodium (STVNA) (1)
- kidney ischemia/reperfusion injury (1)
- low-grade glioma (1)
- mRNA (1)
- mice (1)
- microRNA (1)
- microvascular endothelial cells (1)
- molecular docking (1)
- molecular dynamics (1)
- molecular liphophilicity potential (1)
- multiwalled carbon nanotube (1)
- necrosis factor alpha (1)
- nervous system (1)
- neuroprotection (1)
- neuroscience (1)
- nitric oxide (1)
- organoids (1)
- organotypic hippocampal slice cultures (OHSC) (1)
- oxygen-glucose deprivation (1)
- pharmaceutical applications (1)
- primary microvascular endothelial cells (1)
- propranolol (1)
- protein (1)
- receptor antagonist (1)
- recurrence (1)
- relapse (1)
- safety (1)
- senescence (1)
- sevoflurane (1)
- tight junction protein (1)
- traumatic brain injury (1)
- tumor slice cultures (1)
- ulfobutylether-\(\beta\)-cyclodextrin (1)
- water (1)
Institut
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (13)
- Neurochirurgische Klinik und Poliklinik (8)
- Pathologisches Institut (2)
- Institut für Anatomie und Zellbiologie (1)
- Institut für Pharmazie und Lebensmittelchemie (1)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (1)
- Medizinische Klinik und Poliklinik I (1)
- Neurologische Klinik und Poliklinik (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
Early treatment with glucocorticoids could help reduce both cytotoxic and vasogenic edema, leading to improved clinical outcome after stroke. In our previous study, isosteviol sodium (STVNA) demonstrated neuroprotective effects in an in vitro stroke model, which utilizes oxygen-glucose deprivation (OGD). Herein, we tested the hypothesis that STVNA can activate glucocorticoid receptor (GR) transcriptional activity in brain microvascular endothelial cells (BMECs) as previously published for T cells. STVNA exhibited no effects on transcriptional activation of the glucocorticoid receptor, contrary to previous reports in Jurkat cells. However, similar to dexamethasone, STVNA inhibited inflammatory marker IL-6 as well as granulocyte-macrophage colony-stimulating factor (GM-CSF) secretion. Based on these results, STVNA proves to be beneficial as a possible prevention and treatment modality for brain ischemia-reperfusion injury-induced blood–brain barrier (BBB) dysfunction.